Kang Peng Technology (688602.SH) reported first-quarter results, net profit of 19.1751 million yuan, a year-on-year decrease of 10.89%
According to Zhitong Finance App News, Kang Peng Technology (688602.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 169 million yuan, a year-on-year decrease of 23.02%; net profit attributable to shareholders of listed companies was 19.1751 million yuan, a year-on-year decrease of 10.89%; non-recurring net profit and loss attributable to shareholders of listed companies deducted 15.3814 million yuan; basic earnings per share were 0.04 yuan/share.
The A-share diet pill concept fluctuated higher. Kanghui Pharmaceutical went up and down, Kangpeng Technology rose more than 6%, and Nanowei Technology, Haoyuan Pharmaceutical, Medici, and Prius followed suit.
The A-share diet pill concept fluctuated higher. Kanghui Pharmaceutical went up and down, Kangpeng Technology rose more than 6%, and Nanowei Technology, Haoyuan Pharmaceutical, Medici, and Prius followed suit.
Kang Peng Technology (688602.SH): LiFSi can be used in semi-solid state batteries
Gelonghui, March 18 | Kang Peng Technology (688602.SH) said on the investor interactive platform that (1) According to the currently known technology path, LiFSi can be used for semi-solid state batteries. (2) Product market prices are affected by various factors such as changes in market supply and demand. Currently, market competition is relatively intense.
Kang Peng Technology (688602.SH): 6.444,500 restricted shares will be listed and circulated from January 22
Kang Peng Technology (688602.SH) issued an announcement regarding the initial public offering of restricted shares for offline placement. This time...
Kang Peng Technology (688602): One of the leaders in the domestic fluorine-containing fine chemical industry is optimistic about the company's medium- to long-term growth
The allocation of two major sectors, new materials, pharmaceuticals, and pesticide chemicals establishes a stable revenue stream in diversified downstream application fields. Kangpeng Technology is a high-tech enterprise engaged in R&D, production and sales of fluorine-containing fine chemicals. The company uses specialty chemicals containing fluorine
Kangpeng Technology (688602.SH): The company has technical reserves related to PEEK key monomers
Gelonghui, December 21|Kang Peng Technology (688602.SH) said on the investor interactive platform on December 21 that the company has technical reserves related to key PEEK monomers.
Kangpeng Technology (688602.SH): Currently, the company has not put into production 4,4'-difluorobiphenyl ketone (DFBP)
Glonghui December 21丨Kang Peng Technology (688602.SH) said on the investor interactive platform on December 21 that the company has not yet put into production 4,4'-difluorobenzophenone (DFBP).
Kangpeng Technology (688602.SH): The company currently has no plans to start PEEK production
Gelonghui December 21丨Kang Peng Technology (688602.SH) said on the investor interactive platform on December 21 that the company currently has no plans to launch PEEK production.
Kangpeng Technology (688602.SH): Proposes to sell 4.2105% of shares in the participating company Shanghai Zhongke Kangrun
Gelonghui December 20丨Kangpeng Technology (688602.SH) announced that Shanghai Zhongke Kangrun is a shareholding company. Currently, the company holds 43.2692% of Shanghai Zhongke Kangrun's shares, and the equity law confirms that the initial investment cost is RMB 500.00 million. Yuelin Fund plans to transfer its registered capital of RMB 2,4327.49 million from the company at a price of RMB 20.0 million, and Jiaqiao Capital plans to transfer its registered capital of RMB 243.2749 million from the company at a price of RMB 20.00 million
Kangpeng Technology (688602.SH): Net profit for the third quarter was 377.492 million yuan, down 18.04% year on year
Glonghui, October 25: Kang Peng Technology (688602.SH) announced its report for the third quarter of 2023. Revenue for the reporting period was 269 million yuan, down 23.01% year on year; net profit attributable to shareholders of listed companies was 377.492 million yuan, down 18.04% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 116.331 million yuan, down 75.09% year on year; basic earnings per share were 0.08 yuan/share.
Kangpeng Technology (688602.SH): The main product, LiFSI, is more suitable for high-voltage fast charging systems
Glonghui, Oct. 12 | Kang Peng Technology (688602.SH) said on an interactive platform that under fast charging conditions, there are higher requirements for the ionic conductivity and thermal stability of electrolytes, and the company's main product, LiFSi, is more suitable for high-voltage fast charging systems. The development of fast charging will have a certain positive impact on the company. The liquid crystal display materials produced by the company are mainly used in the production terminal LCD hybrid, and the recovery of consumer electronics will have a certain positive impact on the company.
The photoresist sector quickly rebounded to 2 boards in 3 days of Kangpeng Technology
Gelonghui September 1 | Kangpeng Technology has been on the 2nd market in 3 days. Tongyi shares have risen 15%, while Xinlai Yingcai, Anji Technology, Guangxin Materials, and Yida Co., Ltd. have soared.
The number of new science and technology innovation boards is once again active, and Shengbang Safety has 3 consecutive boards
Gelonghui, August 31 | Shengbang Safety is connected to 20CM3, Kangpeng Technology surged by more than 15%, while Fluorite Network, Sinan Navigation, Guangzhou Steel Gas, and South Aerospace Lake followed suit.
Kangpeng Technology (688602.SH): Plans to use no more than 800 million yuan of idle raised funds for cash management
Glonghui, August 27丨Kangpeng Technology (688602.SH) announced that the company plans to use no more than RMB 800.00 million of the funds raised temporarily for cash management. Within the above amount, the funds can be recycled and used on a rolling basis. According to the usage of the funds raised, the company will carry out cash management of the idle funds raised in installments according to different periods of time. The maximum period shall not exceed 12 months. It is valid for 12 months from the date of review and approval by the company's shareholders' meeting.
The 2 big meat sticks went wild on the first day! N Zhixin (301512.SZ) surged 136%, triggering a temporary suspension with a maximum profit of over 26,000 yuan
The Zhitong Finance App learned that on July 20, a total of 3 new shares were listed, namely N Zhixin of GEM (301512.SZ), N Kang Peng (688602.SH) of the Science and Technology Innovation Board, and N Jinbo (832982.BJ) of the Beijing Stock Exchange. Among them, the IPO Zhixin Precision surged 136% intraday, triggering a moratorium. Jinbo Biotech, which is also listed today, saw the biggest increase in early trading by more than 190%, with a profit of over 9,000 yuan on the China Stock Exchange, making it the biggest bookmark on the Beijing Stock Exchange this year. Another IPO, Kangpeng Technology, rose more than 50% at the opening, and the increase fell back to 38.57% at the close.
Kangpeng Technology (688602.SH): Shares will be listed on the Science and Technology Innovation Board on July 20
GLONGHUI July 18丨Kang Peng Technology (688602.SH) announced that the company's shares will be listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange on July 20, 2023.
Kang Peng Technology (688602.SH): A total of 5,3,552 winning numbers have been won
On the morning of July 12, 2023 (T+1), GLONGHUI | Kang Peng Technology (688602.SH) announced that on the morning of July 12, 2023 (T+1), the issuer and sponsor (lead underwriter) held a lottery ceremony for the online purchase of this distribution at Room 707, North Tower, Shanghai Securities Building, No. 528 Pudong South Road, Pudong New Area, Shanghai. The horoscope ceremony was carried out in accordance with the principles of openness, fairness, and impartiality. The process and results have been notarized by the Shanghai Oriental Notary Office. The winning results are as follows: If an investor participating in the online issuance to purchase Kangpeng Technology shares holds the last number of subscription numbers with the same number as the above number, the winning number is the winning number. The winning draw
Kang Peng Technology (688602.SH): The final winning rate for online distribution was 0.049%
Glonway, July 11丨Kangpeng Technology (688602.SH) announced that according to the rebate mechanism announced in the “Shanghai Kangpeng Technology Co., Ltd. Initial Public Offering of Shares and Issuance Notice on the Science and Technology Innovation Board”, since the initial effective subscription multiplier for this online offering was about 3,074.62 times, more than 100 times, the issuer and sponsor (lead underwriter) decided to initiate a callback mechanism to adjust the scale of offline and online issuance, that is, 10% of the number of publicly issued shares after deducting part of the final strategic placement (rounded up to an integer of 500 shares, that is, 9.175 million shares) Shares from the Internet
Today's IPO Reminder
GLONGHUI July 11丨Kang Peng Technology, subscription code: 787602, issue price: 866 yuan; subscription limit: 17,500 shares; maximum purchase requires a market value of 175,000 yuan. Gangtong Healthcare, subscription code 301,515, issue price is 31.16 yuan, subscription limit is 0.7 million shares, and the maximum subscription requires a market value of 70,000 yuan. Vico Precision has a subscription code of 301,499, an issue price of 19.50 yuan, a maximum purchase limit of 0.95 million shares, and a maximum subscription with a market value of 95,000 yuan. Ford, subscription code 301,446, issue price 31.89 yuan, subscription limit 2.0
Kangpeng Technology (688602.SH) IPO is priced at 8.66 yuan/share, purchased on July 11
GLONGHUI, July 9: Kangpeng Technology (688602.SH) issued an initial public offering of shares and listing on the Science and Technology Innovation Board. After excluding the invalid offer and the highest price, the issuer and sponsor (lead underwriter) comprehensively assessed the company's reasonable investment value, comparable company secondary market valuation level, and secondary market valuation level of the industry to which it belongs based on factors such as the effective subscription multiplier, market conditions, capital raising requirements and underwriting risk of offline investors, fully considering factors such as the effective subscription multiplier, market conditions, capital raising requirements and underwriting risk of the current issuance. The offline subscription date and start and end time is 2023
No Data